Conversely, another bladder cancer study has identified high IgG1/IgA ratios predicts better survival outcomes, which are associated with elevated CD80 expression, enhanced IL-21-mediated signaling, checkpoint modulation, FcγR signaling, and receptor-mediated phagocytosis and endocytosis (80). The gene discussed is CD79A; the disease is urinary bladder cancer.